Gold Serum Levels in Children with Juvenile Rheumatoid Arthritis

References

• Adams A. H., Cecil R. L. Gold therapy in early rheumatoid arthritis. Ann Intern Med 1950; 33: 163
   PubMed Web of Science ®Google Scholar
• Ansell B. M. The management of juvenile chronic polyarthritis. Practitioner 1972; 208: 91
   PubMedGoogle Scholar
• Bahous I., Muller W., Stojan B. Die Bedeutung der Serumgoldspiegelbestimmungen während Chrysotherapie bei chronischer Polyarthritis. Med Clin 1975; 70: 1516
   Google Scholar
• Bardfeld R., Havelka S. Die Stellung der Goldtherapie im Behandlungsplan der juvenilen rheumatoiden Arthritis. Kinderaerztl Prax 1975; 43: 536
   Google Scholar
• Bille B. S. V. Kronisk polyartrit hos barn och dess guldbehandling. Nord Med 1948; 37: 307
   PubMedGoogle Scholar
• Billings R., Grahame R., Marks V., Wood P. J., Taylor A. Blood and urine gold levels during chrysotherapy for rheumatoid arthritis. Rheumatol Rehabil 1975; 13: 14
   Google Scholar
• Bojkinov I., Raikov K. Goldbehandlung bei Kindern mit rheumatoider Arthritis. Monatsschr Kinderheilkd 1970; 118: 444
   PubMedGoogle Scholar
• De Bosset P. L., Bitter T. Near cytotoxic gold salt therapy in long-standing drug refractory rheumatoid arthritis. A prospective investigation. Schweiz Med Wochenschr 1973; 103: 1153
   PubMedGoogle Scholar
• Calabro J. J. Juvenile rheumatoid arthritis: early diagnosis, management, and prognosis. Med Coll Va Quarts 1974; 10
   Google Scholar
• Calabro J. J., Holgerson W. B. Juvenile rheumatoid arthritis: A general review and report of 100 patients observed for 15 years. Sem Arthr Rheumat 1976; 5: 257
   PubMedGoogle Scholar
• Edström G. Chrysotherapy and its “toxic” reactions in rheumatoid arthritis. Acta Med Scand 1948; 131: 571
   Google Scholar
• Fraser T. N. Gold treatment in rheumatoid arthritis. Ann Rheum Dis. 1945; 4: 71
   PubMed Web of Science ®Google Scholar
• Freyberg R. H. Gold therapy of rheumatoid arthritis. Arthritis and Allied Conditions, 8th ed., J. L. Hollander, D. J. McCarty, Jr. Lea & Febiger, Philadelphia 1972; 455–482
   Google Scholar
• Freyberg R. H., Block W. D., Levey S. Metabolism, toxicity and manner of action of gold compounds used in the treatment of arthritis. J Clin Invest 1941; 20: 401
   PubMedGoogle Scholar
• Freyberg R. H., Block W. D., Wells G. S. Gold therapy for rheumatoid arthritis; considerations based upon studies of metabolism of gold. Clinics 1942; 1: 537
   Google Scholar
• Fyfe W. M. Rheumatoid arthritis in childhood. Glasgow Med J 1955; 36: 102
   Google Scholar
• Gerber R. C, Paulus H. E., Bluestone R., Pearson C. M. Clinical response and serum gold levels in chrysotherapy, lack of correlation. Ann Rheum Dis 1972; 31: 308
   PubMed Web of Science ®Google Scholar
• Gottlieb N. L., Smith P. M., Smith E. M. Gold excretion correlated with clinical course during chrysotherapy in rheumatoid arthritis. Arthritis Rheum 1972; 15: 582
   PubMed Web of Science ®Google Scholar
• Gottlieb N. L., Smith P. M., Smith E. M. Pharmacodynamics of 197Au and 195Au labeled aurothiomalate in blood. Correlation with course of rheumatoid arthritis, gold toxicity and gold excretion. Arthritis Rheum 1974; 17: 171
   PubMed Web of Science ®Google Scholar
• Hanson V., Hicks R., Kornreich H. Gold therapy in the treatment of juvenile rheumatoid arthritis. XIII internat. (Congress für Pädiatrie, Wien, 29 Aug. bis 4 Sept., 1971. Verlag der Wiener Med. Akademie, IV–32; 169
   Google Scholar
• Harth M. Serum gold levels during chrysotherapy with relation to urinary and fecal excretion. Clin Pharmacol Ther 1974; 354: 15
   Google Scholar
• Hutto J. H., Jr, Ayoub E. M. Juvenile rheumatoid arthritis at University of Florida. Six-year experience. J Med Assoc 1977; 64: 358
   Google Scholar
• Jessop J. D., Johns R. G. S. Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate. Ann Rheum Dis 1973; 32: 228
   PubMed Web of Science ®Google Scholar
• McKenzie J. M. M. An initial report on a double-blind trial comparing small and large doses of gold in the treatment of rheumatoid disease. Rheumatol Rehabil 1977; 16: 78
   Google Scholar
• Krusius F.-E., Markkanen A., Peltola P. Plasma levels and urinary excretion of gold during routine treatment of rheumatoid arthritis. Ann Rheum Dis 1970; 29: 232
   PubMed Web of Science ®Google Scholar
• Kölle G. Derzeitige Behandlung der juvenilen rheumatoiden Arthritis (=juvenile chronische Polyarthritis) und des Still-Syndroms. Monatsschr Kinderheilkdi 1968; 116: 529
   Google Scholar
• Lorber A., Atkins C. J., Chang C. C, Lee Y. B., Starrs J., Bovy R. A. Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis. Ann Rheum Dis 1973; 32: 133
   PubMed Web of Science ®Google Scholar
• Lorber A., Bovy R. A., Chang C. C. Relationship between serum gold content and distribution to serum immunoglobulins and complement. Nature (London) New Biol 1972; 236: 250
   Google Scholar
• Moller P. W., Ansell B. M., Bywaters E. G. L. Myocrisin therapy in Still's disease. 12th International Congress of Rheumatic Diseases, Prague, 1969
   Google Scholar
• Mäkelä A.-L., Yrjänä T. Serum gold levels in children with juvenile rheumatoid arthritis. OsloNorway March 21st-24th/25th, 1977, EU-LAR/WHO workshop on the care of rheumatic children
   Google Scholar
• Palmer D. G., Dunckley J. V. Gold levels in serum during the treatment of rheumatoid arthritis with gold sodium thiomalate. Aust NZ J Med 1973; 461: 3
   Google Scholar
• Sairanen E., Laaksonen A.-L. The toxicity of gold therapy in children suffering from rheumatoid arthritis. Ann Paediatr Fenn 1962; 2: 105
   Google Scholar
• Sairanen E., Laaksonen A.-L. The results of gold therapy in juvenile rheumatoid arthritis. Ann Paediatr Fenn 1964; 10: 274
   PubMedGoogle Scholar